Global Pharma Medicine Congress Set for Berlin in March
Further details about the 17th International Conference on Pharmaceutical Medicine (ICPM 2014) have been unveiled.
Further details about the 17th International Conference on Pharmaceutical Medicine (ICPM 2014) have been unveiled.
The congress is jointly organized by the International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP) and the German Society of Pharmaceutical Medicine (Deutsche Gesellschaft für Pharmazeutische Medizin e.V.’ – DGPharMed).
“Drug development aiming for true innovations has become even more challenging in the past decade. The investments needed further increased, hurdles for approval and reimbursement became more demanding. In a globalized environment all economic regions are directly competing for R&D leadership in drug development,” noted the organizers, adding that the Berlin meeting will focus on the major framework conditions in that field.
The motto of the event is “The World Is Our Partner”. Beyond assessment of the status quo, the presentations will provide participants with an outlook on what it will take to stay on top of drug development. Experts will address the key topics relevant for smart development of better drugs, and there will also be exchange and networking with peers to discuss presentations and new topics.
To read the full release click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
